The purpose of this systematic literature review (SLR) was to assess current data on burden of survival for pediatric CXT
patients receiving platinum-based regimens in terms of hearing loss, specifically related to costs and quality of life (QoL)-based metrics.
Authors
Kalin Hennegan, Abigail Silber, Sumudu Dehipawala, Kevin Chithran, Donna Lockhart
Journal
ISPOR Meeting; May 2020